CD64 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD64 monoclonal antibodies for advanced research in immunology and cell biology. CD64 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD64, also known as FcγRI, is a high-affinity receptor for the Fc region of immunoglobulin G (IgG) and plays a crucial role in the immune response by mediating phagocytosis and the activation of immune cells. Its expression is primarily found on macrophages and dendritic cells, making it essential for the clearance of pathogens and the regulation of inflammation. Understanding CD64 function is vital for developing therapeutic strategies against various diseases, including infections and autoimmune disorders. CD64 monoclonal antibodies enable precise detection and characterization of CD64 expression patterns in different cell types. Researchers can utilize CD64 monoclonal antibodies to investigate cellular signaling pathways and immune cell interactions. CD64 monoclonal antibodies support detailed analysis of receptor-ligand binding mechanisms and downstream effects. Santa Cruz Biotechnology monoclonal antibodies for CD64 empower researchers worldwide to advance our understanding of immune system regulation and disease mechanisms.